Ekbom Spectrum Psychosis Associated with 24-hour Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson’s Disease
Clin Psychopharmacol Neurosci. 2026 Nov 30;24(4):885-889. doi: 10.9758/cpn.26.1449. Epub 2026 Oct 4.ABSTRACTContinuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI) is an emerging treatment for advanced Parkinson's disease (PD)....
